AR008491A1 - Vacuna contra la micosis, procedimiento para su preparacion y su uso para la profilaxis y/o el tratamiento de la micosis - Google Patents

Vacuna contra la micosis, procedimiento para su preparacion y su uso para la profilaxis y/o el tratamiento de la micosis

Info

Publication number
AR008491A1
AR008491A1 ARP970104552A ARP970104552A AR008491A1 AR 008491 A1 AR008491 A1 AR 008491A1 AR P970104552 A ARP970104552 A AR P970104552A AR P970104552 A ARP970104552 A AR P970104552A AR 008491 A1 AR008491 A1 AR 008491A1
Authority
AR
Argentina
Prior art keywords
mycosis
prophylaxis
treatment
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Suspension/Interruption
Application number
ARP970104552A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Original Assignee
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Vetmedica GmbH, Boehringer Ingelheim Vetmedica de C V SA filed Critical Boehringer Ingelheim International GmbH
Publication of AR008491A1 publication Critical patent/AR008491A1/es
Suspension/Interruption legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/165—Yeast isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/72—Candida
    • C12R2001/725—Candida albicans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Vacunas que comprenden blastoesporas de levadura inactivadas y homogeizadas y microconidios de dermatofitos inactivados y homogeneizados o el materialantigénico de dichas esporas, a métodos para su produccion y a su uso para la profilaxis y/oel tratamiento de micosis en mamíferos, preferiblemente sereshumanos. Las vacunas de acuerdo con el presente invento son especialmente utiles para la profilaxis y/o el tratamiento de micosis cutáneas,preferiblemente dermatomicosis y/ocandidosis y/u onicomicosis.
ARP970104552A 1996-10-04 1997-10-03 Vacuna contra la micosis, procedimiento para su preparacion y su uso para la profilaxis y/o el tratamiento de la micosis Suspension/Interruption AR008491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96115954A EP0834322A3 (en) 1996-10-04 1996-10-04 Mycosis vaccine

Publications (1)

Publication Number Publication Date
AR008491A1 true AR008491A1 (es) 2000-01-19

Family

ID=8223269

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104552A Suspension/Interruption AR008491A1 (es) 1996-10-04 1997-10-03 Vacuna contra la micosis, procedimiento para su preparacion y su uso para la profilaxis y/o el tratamiento de la micosis

Country Status (17)

Country Link
US (1) US6290950B1 (es)
EP (2) EP0834322A3 (es)
JP (1) JP4698771B2 (es)
AR (1) AR008491A1 (es)
AT (1) ATE347372T1 (es)
AU (1) AU740389B2 (es)
CA (1) CA2268138C (es)
CO (1) CO4650185A1 (es)
DE (1) DE69737067T2 (es)
DK (1) DK0956042T3 (es)
ES (1) ES2279546T3 (es)
HR (1) HRP970528A2 (es)
PE (1) PE2399A1 (es)
PT (1) PT956042E (es)
RU (1) RU2219945C2 (es)
WO (1) WO1998015284A2 (es)
ZA (1) ZA978799B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
US6720576B1 (en) * 1992-09-11 2004-04-13 Semiconductor Energy Laboratory Co., Ltd. Plasma processing method and photoelectric conversion device
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
WO2001015725A1 (en) * 1998-09-24 2001-03-08 Alpharma As Vaccine for the protection of a vertebrate animal against fungal skin infection
EP1303300B1 (en) * 2000-06-19 2010-08-11 Hunter Immunology Limited Compositions and methods for treatment of candidiasis
US20040043003A1 (en) * 2002-01-31 2004-03-04 Wei Chen Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
US20040009937A1 (en) * 2002-01-31 2004-01-15 Wei Chen Methods and composition for delivering nucleic acids and/or proteins to the respiratory system
US20050075298A1 (en) * 2002-01-31 2005-04-07 Wei Chen Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
RU2281110C1 (ru) * 2005-02-10 2006-08-10 Владислав Николаевич Ласкавый Лекарственное средство против кандидоза человека для инъекций
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US20080220023A1 (en) * 2007-03-08 2008-09-11 Stevens David A Antifungal vaccines with saccharomyces cerevisiae
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
PT3429616T (pt) 2016-03-15 2021-09-17 Igor Polyakov Composições para o tratamento e prevenção de doenças dos cascos e das garras
WO2017158040A1 (en) 2016-03-15 2017-09-21 Igor Polyakov New immunobiological products
WO2021001540A1 (en) 2019-07-04 2021-01-07 Proxi Biotech Aps Detoxification of proteins

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU547928B2 (en) * 1981-11-03 1985-11-14 Sutka, K. Antigenic preparation from candida guilliermondii
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
CA2011896C (en) 1989-04-21 2001-05-08 Mark Werner Ringworm vaccine
DE4007927A1 (de) * 1990-03-13 1991-09-19 Bayer Ag Pathogenese-faktoren von dermatophyten
US5277904A (en) * 1990-10-26 1994-01-11 Pier Allan C Broad spectrum dermatophyte vaccine
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
GB9417880D0 (en) * 1994-09-06 1994-10-26 Auspharm Int Ltd Vaccine
GB2304347A (en) * 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
KR100524245B1 (ko) * 1996-09-04 2005-10-26 다카라 바이오 가부시키가이샤 진균항원 및 그의 제조방법

Also Published As

Publication number Publication date
EP0956042B1 (en) 2006-12-06
ATE347372T1 (de) 2006-12-15
AU740389B2 (en) 2001-11-01
CA2268138C (en) 2009-01-06
EP0956042A2 (en) 1999-11-17
ES2279546T3 (es) 2007-08-16
US6290950B1 (en) 2001-09-18
DE69737067D1 (de) 2007-01-18
HRP970528A2 (en) 1998-08-31
PT956042E (pt) 2007-04-30
JP2001503975A (ja) 2001-03-27
WO1998015284A3 (en) 1999-09-23
DK0956042T3 (da) 2007-04-10
PE2399A1 (es) 1999-02-10
RU2219945C2 (ru) 2003-12-27
CO4650185A1 (es) 1998-09-03
EP0834322A3 (en) 1998-04-22
CA2268138A1 (en) 1998-04-16
EP0834322A2 (en) 1998-04-08
DE69737067T2 (de) 2007-07-05
WO1998015284A2 (en) 1998-04-16
JP4698771B2 (ja) 2011-06-08
AU4460497A (en) 1998-05-05
ZA978799B (en) 1998-04-06

Similar Documents

Publication Publication Date Title
AR008491A1 (es) Vacuna contra la micosis, procedimiento para su preparacion y su uso para la profilaxis y/o el tratamiento de la micosis
CY1106429T1 (el) Μαξιλαρι καταλληλο για το γυναικειο σωμα
PT1411908E (pt) Tratamento de infeccoes da unha com no
SE9900519D0 (sv) A method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
AR015257A1 (es) UNA COMPOSICION ACIDIFICADA Y EL USO DE DICHA COMPOSICION PARA LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO ToPICO DE CONDICIONES DE LAS UNAS Y DE LA PIEL
CY1105343T1 (el) Σταφυλοκοκκικη πρωτεϊνη αναστολης του χημειοτακτισμου (chips) και η χρηση αυτης
UY28313A1 (es) Nonadepsipeptidos acilados
CL2022001185A1 (es) Derivados terapéuticos de interleucina-22
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
CY1107538T1 (el) Εμβολιο μυκοπλασματος αδρανοποιημενο με σαπωνινη
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
ECSP972274A (es) Vacunas de micosis
PA8552301A1 (es) Metodo para el tratamiento de insomnio primario
DE60135318D1 (de) Rekombinante bcg-impfstoffe gegen intrazelluläre pathogene und anwendungsverfahren
ES2177987T3 (es) Articulos moldeados de celulosa hidratada con superficie enzimaticamente modificada.
CY1105629T1 (el) Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv
UY24853A1 (es) Procedimiento para preparar vacunas de micosis
AR029451A1 (es) Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia
HUP9702355A2 (hu) Avirulens Mycoplasma synoviae, és az ezt tartalmazó vakcina
ES2145114T3 (es) Combinacion de atovacuona con proguanil para el tratamiento de infecciones protozoarias.
AR020141A1 (es) Toxinas y genes pesticidas de cepas de bacillus laterosporus
ES2080024B1 (es) Vacuna subunitaria recombinante contra la enfermedad hemorragica virica de los conejos.
PA8579401A1 (es) Derivados de 2,3-dihidro-isoindol-1-ona como inhibidores de mao-b
HUP0000146A2 (hu) Eljárás Streptococcus pneumoniae-fertőzés kezelésére

Legal Events

Date Code Title Description
FB Suspension of granting procedure